by admin | Nov 13, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Sarah C.P. Williams, UCLA – Phys.org News Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA are one step closer to developing stem cell therapies to regenerate skeletal muscle in humans. Working in mice,...
by admin | Nov 10, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Tristan Epps – Penn Medicine News Ben Stanger, MD, PhD is a practicing Gastroenterologist at Penn Medicine. He is also the Hanna Wise Professor in Cancer Research and professor of Medicine and Cell and Developmental biology at the University of Pennsylvania....
by admin | Nov 9, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions, Video
By Marla Paul – Northwestern Medicine Synthetic cream also protects skin from sun damage Imagine a skin cream that heals damage occurring throughout the day when your skin is exposed to sunlight or environmental toxins. That’s the potential of a synthetic,...
by admin | Nov 6, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia (RPD) with reasonably high confidence during a patient’s first clinical visit. This scoring criteria may allow physicians...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/U5VZBBJ5SBJARD5TTCJHHDF6VM.jpg "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study")
by admin | Nov 5, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Reuters News Oct 31 (Reuters) – A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval. If...
by admin | Nov 3, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Japan Times A Japanese medical institution, in a first for the country, will seek government approval for using embryonic stem cells as a regenerative medicine product to treat babies with a severe liver ailment, sources close to the matter said Monday. The step...
